Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,899 | 7,650 | 4,369 | 8,191 | 5,409 |
| Receivables | 53,877 | 50,438 | 56,356 | 47,851 | 47,083 |
| Inventories | 31,819 | 28,749 | 30,836 | 28,139 | 25,290 |
| Other current assets | 510 | 0 | 0 | 0 | 0 |
| TOTAL | $97,063 | $94,451 | $95,987 | $88,520 | $81,280 |
| Non-Current Assets | |||||
| PPE Net | 159,624 | 143,362 | 135,271 | 132,637 | 133,220 |
| Investments And Advances | 66,500 | 65,800 | 65,800 | 64,500 | 63,600 |
| Intangibles | 76,352 | 76,859 | 77,098 | 77,369 | 77,590 |
| Other Non-Current Assets | 5,164 | 5,364 | 5,152 | 3,941 | 2,918 |
| TOTAL | $307,640 | $291,385 | $283,321 | $278,447 | $277,328 |
| Total Assets | $404,703 | $385,836 | $379,308 | $366,967 | $358,608 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,940 | 16,940 | 14,940 | 15,440 | 7,940 |
| Accounts payable and accrued liabilities | 34,668 | 35,240 | 37,483 | 26,951 | 25,868 |
| Accrued Expenses | 9,978 | 6,732 | 7,624 | 5,386 | 8,211 |
| TOTAL | $88,375 | $71,187 | $70,191 | $57,812 | $51,454 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,360 | 38,595 | 39,829 | 41,064 | 42,299 |
| Deferred Revenues | 2,625 | 1,906 | 1,673 | 284 | 310 |
| Other Non-Current Liabilities | 5,280 | 6,415 | 6,837 | 7,473 | 8,391 |
| TOTAL | $63,766 | $64,499 | $76,408 | $77,986 | $79,002 |
| Total Liabilities | $152,141 | $135,686 | $146,599 | $135,798 | $130,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 27,564 | 27,534 | 27,507 | N/A |
| Common Shares | 28 | 28 | 28 | 28 | 27 |
| Retained earnings | 109,299 | 103,191 | 87,103 | 86,616 | 84,470 |
| Other shareholders' equity | 1,148 | 2,433 | 2,088 | 1,938 | 1,975 |
| TOTAL | $252,562 | $250,150 | $232,709 | $231,169 | $228,152 |
| Total Liabilities And Equity | $404,703 | $385,836 | $379,308 | $366,967 | $358,608 |